SER Financial Statements

Balance sheet, income statement, cash flow, and dividends for Agex Therapeutics Inc (SER).


$44.55M Market Cap.

As of 03/24/2025 5:00 PM ET (MRY) • Disclaimer

SER Market Cap. (MRY)


SER Shares Outstanding (MRY)


SER Assets (MRY)


Total Assets

$6.72M

Total Liabilities

$6.22M

Total Investments

$0

SER Income (MRY)


Revenue

$56.00K

Net Income

-$11.14M

Operating Expense

$17.10M

SER Cash Flow (MRY)


CF Operations

-$17.14M

CF Investing

-$22.00K

CF Financing

$13.21M

SER Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SER Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$6,724,000 (-43.80%)

$11,965,000 (269.18%)

$3,241,000 (2.76%)

$3,154,000 (-19.64%)

Assets Current

$5,676,000 (652.79%)

$754,000 (-69.26%)

$2,453,000 (9.80%)

$2,234,000 (-2.15%)

Assets Non-Current

$1,048,000 (-90.65%)

$11,211,000 (1322.72%)

$788,000 (-14.35%)

$920,000 (-43.97%)

Goodwill & Intangible Assets

$0 (0%)

$607,000 (-17.75%)

$738,000 (-15.17%)

$870,000 (-45.35%)

Shareholders Equity

$641,000 (-88.28%)

$5,469,000 (131.77%)

-$17,212,000 (-45.47%)

-$11,832,000 (-131.27%)

Property Plant & Equipment Net

$1,048,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$3,672,000 (829.62%)

$395,000 (-43.17%)

$695,000 (9.62%)

$634,000 (20.30%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$10,554,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$10,554,000 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$57,000 (1325.00%)

$4,000 (-84.00%)

$25,000 (-92.33%)

Trade & Non-Trade Payables

$744,000 (-66.82%)

$2,242,000 (90.81%)

$1,175,000 (39.71%)

$841,000 (-51.30%)

Accumulated Retained Earnings (Deficit)

-$44,318,000 (66.17%)

-$131,013,000 (-12.74%)

-$116,210,000 (-9.89%)

-$105,748,000 (-8.94%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$268,000 (-93.86%)

$4,365,000 (-75.92%)

$18,124,000 (37.28%)

$13,202,000 (109.69%)

Debt Current

$0 (0%)

$3,672,000 (-51.97%)

$7,646,000 (7.09%)

$7,140,000 (198.00%)

Debt Non-Current

$268,000 (-61.33%)

$693,000 (-93.39%)

$10,478,000 (72.85%)

$6,062,000 (55.44%)

Total Liabilities

$6,216,000 (-5.92%)

$6,607,000 (-67.86%)

$20,556,000 (36.78%)

$15,029,000 (61.24%)

Liabilities Current

$2,366,000 (-59.99%)

$5,914,000 (-41.32%)

$10,078,000 (12.39%)

$8,967,000 (67.39%)

Liabilities Non-Current

$3,850,000 (455.56%)

$693,000 (-93.39%)

$10,478,000 (72.85%)

$6,062,000 (52.93%)

SER Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$56,000 (-60.56%)

$142,000 (317.65%)

$34,000 (-76.39%)

$144,000 (-60.11%)

Cost of Revenue

$0 (0%)

$40,000 (207.69%)

$13,000 (-31.58%)

$19,000 (-26.92%)

Selling General & Administrative Expense

$9,624,000 (3.17%)

$9,328,000 (56.22%)

$5,971,000 (-10.99%)

$6,708,000 (-0.19%)

Research & Development Expense

$7,480,000 (919.07%)

$734,000 (-28.39%)

$1,025,000 (-29.60%)

$1,456,000 (-60.80%)

Operating Expenses

$17,104,000 (71.42%)

$9,978,000 (42.89%)

$6,983,000 (-8.24%)

$7,610,000 (-26.33%)

Interest Expense

$526,000 (-89.27%)

$4,900,000 (46.93%)

$3,335,000 (204.01%)

$1,097,000 (171.53%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$103,000 (-82.15%)

Consolidated Income

-$11,207,000 (24.33%)

-$14,811,000 (-40.76%)

-$10,522,000 (-21.15%)

-$8,685,000 (20.87%)

Net Income to Non-Controlling Interests

-$66,000 (-725.00%)

-$8,000 (86.67%)

-$60,000 (-500.00%)

-$10,000 (90.99%)

Net Income

-$11,141,000 (24.74%)

-$14,803,000 (-41.49%)

-$10,462,000 (-20.60%)

-$8,675,000 (20.16%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$11,141,000 (24.74%)

-$14,803,000 (-41.49%)

-$10,462,000 (-20.60%)

-$8,675,000 (20.16%)

Weighted Average Shares

$7,359,000 (582.02%)

$1,079,000 (-97.16%)

$37,945,000 (0.16%)

$37,886,000 (0.58%)

Weighted Average Shares Diluted

$7,359,000 (582.02%)

$1,079,000 (-97.16%)

$37,945,000 (0.16%)

$37,886,000 (0.58%)

Earning Before Interest & Taxes (EBIT)

-$10,615,000 (-7.19%)

-$9,903,000 (-38.95%)

-$7,127,000 (5.95%)

-$7,578,000 (27.56%)

Gross Profit

$56,000 (-45.10%)

$102,000 (385.71%)

$21,000 (-83.20%)

$125,000 (-62.69%)

Operating Income

-$17,048,000 (-72.62%)

-$9,876,000 (-41.86%)

-$6,962,000 (6.99%)

-$7,485,000 (25.11%)

SER Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$22,000 (99.78%)

-$10,000,000 (0%)

$0 (0%)

$666,000 (3430.00%)

Net Cash Flow from Financing

$13,212,000 (-24.50%)

$17,500,000 (191.67%)

$6,000,000 (-17.20%)

$7,246,000 (21.56%)

Net Cash Flow from Operations

-$17,137,000 (-119.71%)

-$7,800,000 (-31.34%)

-$5,939,000 (24.39%)

-$7,855,000 (-0.49%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,947,000 (-1215.67%)

-$300,000 (-591.80%)

$61,000 (7.02%)

$57,000 (103.04%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$416,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

-$10,000,000 (0%)

$0 (0%)

$250,000 (0%)

Capital Expenditure

-$22,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$2,875,000 (-83.57%)

$17,500,000 (191.67%)

$6,000,000 (-11.11%)

$6,750,000 (10.33%)

Issuance (Purchase) of Equity Shares

$5,012,000 (0%)

$0 (0%)

$0 (0%)

$496,000 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,595,000 (300.46%)

$648,000 (-14.74%)

$760,000 (-23.92%)

$999,000 (9.90%)

Depreciation Amortization & Accretion

$421,000 (221.37%)

$131,000 (-0.76%)

$132,000 (0.76%)

$131,000 (-89.56%)

SER Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (39.28%)

71.80% (16.18%)

61.80% (-28.80%)

86.80% (-6.47%)

Profit Margin

-19894.60% (-90.84%)

-10424.60% (66.12%)

-30770.60% (-410.77%)

-6024.30% (-100.16%)

EBITDA Margin

-18203.60% (-164.52%)

-6881.70% (66.55%)

-20573.50% (-297.82%)

-5171.50% (-102.80%)

Return on Average Equity (ROAE)

131.80% (42.80%)

92.30% (25.92%)

73.30% (-23.80%)

96.20% (-73.55%)

Return on Average Assets (ROAA)

-124.70% (-3.14%)

-120.90% (69.54%)

-396.90% (-29.03%)

-307.60% (-27.21%)

Return on Sales (ROS)

-18955.40% (-171.80%)

-6973.90% (66.73%)

-20961.80% (-298.32%)

-5262.50% (-81.60%)

Return on Invested Capital (ROIC)

-992.30% (-1361.41%)

-67.90% (39.91%)

-113.00% (21.20%)

-143.40% (83.12%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.32 (-236.17%)

-0.99 (49.92%)

-1.97 (58.41%)

-4.74 (9.58%)

Price to Sales Ratio (P/S)

658.37 (539.89%)

102.89 (-83.30%)

615.94 (114.78%)

286.78 (80.81%)

Price to Book Ratio (P/B)

69.5 (2501.01%)

2.67 (319.56%)

-1.22 (65.18%)

-3.5 (68.79%)

Debt to Equity Ratio (D/E)

9.7 (702.73%)

1.21 (201.17%)

-1.19 (5.98%)

-1.27 (30.30%)

Earnings Per Share (EPS)

-1.51 (88.99%)

-13.72 (-4800.00%)

-0.28 (-21.74%)

-0.23 (20.69%)

Sales Per Share (SPS)

0.01 (-93.94%)

0.13 (13100.00%)

0 (-75.00%)

0 (-60.00%)

Free Cash Flow Per Share (FCFPS)

-2.33 (67.74%)

-7.23 (-4504.46%)

-0.16 (24.15%)

-0.21 (0.48%)

Book Value Per Share (BVPS)

0.09 (-98.28%)

5.07 (1216.52%)

-0.45 (-45.51%)

-0.31 (-129.41%)

Tangible Assets Book Value Per Share (TABVPS)

0.91 (-91.32%)

10.53 (15848.48%)

0.07 (10.00%)

0.06 (-3.23%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-150.00%)

-2 (60.00%)

-5 (28.57%)

-7 (-16.67%)

Enterprise Value Over EBITDA (EV/EBITDA)

-5.18 (-208.77%)

-1.68 (67.48%)

-5.16 (26.19%)

-6.99 (-4.24%)

Asset Turnover

0.01 (-50.00%)

0.01 (-7.69%)

0.01 (-74.51%)

0.05 (-36.25%)

Current Ratio

2.4 (1788.98%)

0.13 (-47.74%)

0.24 (-2.41%)

0.25 (-41.55%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$17,159,000 (-119.99%)

-$7,800,000 (-31.34%)

-$5,939,000 (24.39%)

-$7,855,000 (-0.23%)

Enterprise Value (EV)

$52,780,800 (222.16%)

$16,383,235 (-54.58%)

$36,073,033 (-30.67%)

$52,029,702 (-15.68%)

Earnings Before Tax (EBT)

-$11,141,000 (24.74%)

-$14,803,000 (-41.49%)

-$10,462,000 (-20.60%)

-$8,675,000 (20.16%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$10,194,000 (-4.32%)

-$9,772,000 (-39.70%)

-$6,995,000 (6.07%)

-$7,447,000 (19.11%)

Invested Capital

$954,000 (-89.87%)

$9,414,000 (-4.47%)

$9,854,000 (67.44%)

$5,885,000 (114.39%)

Working Capital

$3,310,000 (164.15%)

-$5,160,000 (32.33%)

-$7,625,000 (-13.25%)

-$6,733,000 (-119.03%)

Tangible Asset Value

$6,724,000 (-40.80%)

$11,358,000 (353.78%)

$2,503,000 (9.59%)

$2,284,000 (-2.10%)

Market Capitalization

$44,548,800 (204.89%)

$14,611,235 (-30.23%)

$20,943,033 (-49.36%)

$41,353,702 (-27.81%)

Average Equity

-$8,451,250 (47.29%)

-$16,034,000 (-12.36%)

-$14,270,250 (-58.20%)

-$9,020,500 (-201.94%)

Average Assets

$8,930,750 (-27.07%)

$12,245,750 (364.56%)

$2,636,000 (-6.54%)

$2,820,500 (-37.24%)

Invested Capital Average

$1,069,750 (-92.67%)

$14,593,750 (131.45%)

$6,305,250 (19.30%)

$5,285,000 (329.15%)

Shares

8,891,976 (724.03%)

1,079,080 (-97.16%)

37,947,152 (0.02%)

37,939,176 (0.66%)